Register entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- Japan
Authorisation
Registered operations
Analytical testing1Finished drug manufacture1sterilize1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| TOYOBO CO., LTD. | 2-1-1 Katata, Otsu, 520-0292, Japan (JPN) | Analytical testing, Finished drug manufacture, sterilize | 1000251214695533752 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | mogamulizumab | injection | 72639-0011DRUG FOR FURTHER PROCESSING |
Compare
Comparable companies in Japan
- Sato Pharmaceutical Co., Ltd.1 site · 33 NDC
- Kyowa Kirin Co., Ltd.1 site · 11 NDC
- Kyowa Pharma Chemical Co., Ltd.1 site · 6 NDC
- Juzen Chemical Corporation1 site · 4 NDC
- Toshiki Pigment Company Limited1 site · 4 NDC
- TEIKOKU SEIYAKU CO.,LTD.1 site · 3 NDC
- KAKEN Pharmaceutical Co., LTD1 site · 2 NDC
- KINKANDO CO., LTD1 site · 2 NDC
- Sekisui Medical Co., Ltd.1 site · 2 NDC
- DEMAND SERVICE CO., LTD.1 site · 1 NDC
Enquiry
Common questions
- Is TOYOBO CO., LTD. FDA approved?
- TOYOBO CO., LTD. holds 1 FDA-registered establishment in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are TOYOBO CO., LTD.'s drugs manufactured?
- The FDA register lists Otsu. Registered operations: analytical testing, finished drug manufacture, sterilize.
- What drugs does TOYOBO CO., LTD. make?
- 1 product is listed under TOYOBO CO., LTD. in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.